AG真人官方

STOCK TITAN
  1. Home
  2. Sec-filings
  3. MDGL
  4. [Form 4] Madrigal Pharmaceuticals, Inc. Insider Trading Activity

[Form 4] Madrigal Pharmaceuticals, Inc. Insider Trading Activity

Filing Impact
(Neutral)
Filing Sentiment
(Negative)
Form Type
4

Filing content is currently unavailable.

Source:

Stock MDGL logo
Madrigal Pharmac

NASDAQ:MDGL

MDGL Rankings

#981 Ranked by Market Cap
N/A Ranked by Dividends

MDGL Latest News

Aug 19, 2025
Madrigal Receives European Commission Approval for Rezdiffra鈩� (resmetirom) for the Treatment of MASH with Moderate to Advanced Liver Fibrosis
Aug 11, 2025
Madrigal Pharmaceuticals to Participate in the聽Canaccord Genuity 45th Annual Growth Conference
Aug 7, 2025
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
Aug 5, 2025
Madrigal Pharmaceuticals Reports Second-Quarter 2025 Financial Results and聽Provides Corporate Updates
Jul 30, 2025
Madrigal Pharmaceuticals Enters into Exclusive Global License Agreement for Oral GLP-1 Receptor Agonist with CSPC Pharmaceutical Group Limited

MDGL Latest SEC Filings

Aug 20, 2025
[Form 4] Madrigal Pharmaceuticals, Inc. Insider Trading Activity
Aug 20, 2025
[Form 4] Madrigal Pharmaceuticals, Inc. Insider Trading Activity
Aug 20, 2025
[144] Madrigal Pharmaceuticals, Inc. SEC Filing
Aug 18, 2025
[Form 4] Madrigal Pharmaceuticals, Inc. Insider Trading Activity
Aug 18, 2025
[144] Madrigal Pharmaceuticals, Inc. SEC Filing

MDGL Stock Data

8.72B
20.52M
7.7%
107.15%
17.91%
Biotechnology
Pharmaceutical Preparations
United States
WEST CONSHOHOCKEN